New Mycobactenum avium antifolate shows synergistic effect when used in combination with dihydropteroate synthase inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 11, 2005, Pages 4801-4803

  Suling, W J ^a   Seitz, L E ^a   Reynolds, R C ^a   Barrow, W W ^b  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 (2,5 DIETHOXYPHENYLAMINOMETHYL) 2,4 DIAMINO 5 METHYLPYRIDO[2,3 D]PYRIMIDINE; DIHYDROPTEROATE SYNTHASE; ENZYME INHIBITOR; FOLIC ACID ANTAGONIST; PYRIMIDINE DERIVATIVE; SRI 8858; UNCLASSIFIED DRUG; SRI-8858;

ANTIMICROBIAL ACTIVITY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; CATALYSIS; DERIVATIZATION; DRUG EFFECT; DRUG POTENTIATION; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; DRUG ANTAGONISM; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM INTRACELLULARE AVIUM;

DIHYDROPTEROATE SYNTHASE; DRUG SYNERGISM; ENZYME INHIBITORS; FOLIC ACID ANTAGONISTS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM AVIUM COMPLEX; PYRIMIDINES;

EID: 27644575523     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.11.4801-4803.2005     Document Type: Article

References (7)

1. Collins, L. A., and S. G. Franzblau. 1997. Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41:1004-1009.
2. Elion, G. B., S. Singer, and G. H. Hitchings. 1954. Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites. J. Biol. Chem. 208:477-488.
3. Hartman, P. G. 1993. Molecular aspects and mechanism of action of dihydrofolate reductase inhibitors. J. Chemother. 5:369-376.
4. Hitchings, G. H., Jr. 1989. Nobel lecture in physiology or medicine-1988. Selective inhibitors of dihydrofolate reductase. In Vitro Cell. Dev. Biol. 25:303-310.
5. MacKenzie, R. E. 1984. Biogenesis and interconversion of substituted tetrahydrofolates, p. 256-306. In R. L. Blakley and S. J. Benkovic (ed.), Folates and pterins, vol. 1. John Wiley & Sons, New York, N.Y.
6. Suling, W. J., R. C. Reynolds, E. W. Barrow, L. N. Wilson, J. R. Piper, and W. W. Barrow. 1998. Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase. J. Antimicrob. Chemother. 42:811-815.
7. Suling, W. J., L. E. Seitz, V. Pathak, L. Westbrook, E. W. Barrow, S. Zywnovan-Ginkel, R. C. Reynolds, J. R. Piper, and W. W. Barrow. 2000. Antimycobacterial activity of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase (DHFR). Antimicrob. Agents Chemother. 44:2784-2793.